Provided by Tiger Trade Technology Pte. Ltd.

IMMUNEONCO-B

3.830
+0.1203.23%
Volume:1.13M
Turnover:4.31M
Market Cap:1.64B
PE:-6.20
High:3.930
Open:3.700
Low:3.700
Close:3.710
52wk High:16.800
52wk Low:2.800
Shares:429.00M
HK Float Shares:418.00M
Volume Ratio:1.54
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.618
ROE:-40.11%
ROA:-16.24%
PB:2.25
PE(LYR):-6.20
PS:11.18

Loading ...

IMMUNEONCO-B Repurchases Shares for HK$201,400 on July 8

Stock News
·
Jul 08

Immuneonco Files HKEX Next-day Disclosure Return After Share Repurchase

Reuters
·
Jul 08

IMMUNEONCO-B Repurchases 91,800 H Shares; Treasury Holding Rises to 1.67 Million

Bulletin Express
·
Jul 07

Immuneonco Biopharma Files HKEX Next-day Disclosure Return on Share Buyback

Reuters
·
Jul 07

ImmuneOnco Executes Small-Scale Share Buyback, Expands Treasury Stock to 1.47 Million Shares

Bulletin Express
·
Jul 06

IMMUNEONCO-B Repurchases 108,400 Shares for HK$409,000

Stock News
·
Jul 06

IMMUNEONCO-B buys back 25,400 H shares; treasury stock rises to 1.47 million units

Bulletin Express
·
Jul 03

Immuneonco Files HKEX Next-day Disclosure Return After Share Repurchase at HKD 3.87

Reuters
·
Jul 03

ImmuneOnco faces HKEX non-compliance ruling on RMB Loan to Chairman; details remedial plan

Bulletin Express
·
Jul 02

Immuneonco Biopharmaceuticals (shanghai) - Stock Exchange Finds Immuneonco Loan not on Normal Commercial Terms

THOMSON REUTERS
·
Jul 02

Immuneonco Biopharmaceuticals (shanghai) - as Remedy, to Disclose Non-compliance and Loan Details in Next Annual Report, Others

THOMSON REUTERS
·
Jul 02

Advancing Cancer Treatment Convenience: IMMUNEONCO-B's Subcutaneous Formulation for IMM2510

Stock News
·
Jul 02

IMMUNEONCO-B Repurchases 93,400 H Shares; Treasury Stock Climbs to 1.44 Million

Bulletin Express
·
Jun 26

IMMUNEONCO-B repurchases 133,600 H shares, reducing free float by 0.03%

Bulletin Express
·
Jun 25

IMMUNEONCO-B Repurchases Shares for HK$474,400

Stock News
·
Jun 25

IMMUNEONCO-B Repurchases Shares with HK$1.096 Million Investment

Stock News
·
Jun 24

IMMUNEONCO-B Shares Surge in Morning Session on Promising Lung Cancer Drug Data

Stock News
·
Jun 23

Addressing Unmet Needs in Later-Line Lung Squamous Carcinoma, Accelerated Innovation Delivery Puts IMMUNEONCO-B (01541) in a Prime Position

Stock News
·
Jun 22

ImmuneOnco trims stake in ImmuneCare subsidiary to 80.0% through RMB0.33 million employee-platform capital injection

Bulletin Express
·
Jun 18

IMMUNEONCO-B Subsidiary Secures Additional Investment from Employee Platform

Stock News
·
Jun 18